secwatch.observer — SEC 8-K summary
======================================

Issuer:     2seventy bio, Inc. (—)
CIK:        0001860782
Form:       8-K
Filed at:   2024-04-25T23:59:59+00:00
Accession:  0001860782-24-000060
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

2seventy bio announces Q1 2024 Abecma U.S. revenue of $52M
----------------------------------------------------------

- Abecma generated approximately $52M in U.S. Q1 2024 revenue, unaudited.
- Company and BMS share equally in all profits and losses for Abecma in the U.S.
- Full Q1 2024 results to be announced on or before May 15, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860782/000186078224000060/0001860782-24-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860782/000186078224000060/tvst-20240425.htm
  HTML page:      https://secwatch.observer/filing/0001860782-24-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer